Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Bullboard Posts
Comment by CallMeRocketManon Jan 04, 2018 5:29pm
169 Views
Post# 27284486

RE:RE:buy right now at $2.20

RE:RE:buy right now at $2.20Nope.
Between Sessions crack down today in the USA and Trudeau dragging his feet on an actual legal date, Im starting to feeling safer in the science behind cannabis. Im getting sick of the Raids LOL Fu#k

We can all agree, medical cannabis has huge upside with tremendous health benefits. With Inmed, they have discovered more than 90 cannabaniods in the plant and they have the technology to extract it, mass produce it with the same approach as insulin, as well uncover more hidden health benefits of the plant. The management team is the who's who of the bio science industry. Top notch world class executives.

From this point, companies with science behind them related to cannabis that have made great srides in 2017 is where im at as an investor. INmed, BLO, ATT


Bullboard Posts